ライフサイエンスコーパス: baseline

1 8th-year radiographic findings compared with baseline).

2 repeat of PETco2 at 60 mm Hg; and repeat of baseline).

3 ographic characteristics were ascertained at baseline.

4 ich were identical to the scans conducted at baseline.

5 turn of postintervention creatinine level to baseline.

6 not with cardiovascular disease severity at baseline.

7 /PER3 (5) and PER3 (4) /PER3 (4) subjects at baseline.

8 n the men in the CR group was higher than at baseline.

9 five (7%) of the 40 carotids without IPH at baseline.

10 ample was 8,075 PKR (approximately US$77) at baseline.

11 % occurs in many patients with reduced EF at baseline.

12 tly in patients with and without diabetes at baseline.

13 ected into PAXgene tubes for all subjects at baseline.

14 e (0.008) and lower CSF Abeta1-42 (0.005) at baseline.

15 rum creatinine (Cr) at day 90 was defined as baseline.

16 free of cancer, heart disease, and stroke at baseline.

17 l score (least squares mean [SE] change from baseline -15.6 (1.0) vs -7.9 (1.0), a treatment differen

18 sma metabolites and insulin were measured at baseline, 15, 30, 60, 90 and 120 min after feeding.

19 The purpose of this study was to describe baseline (18)F-FDG PET voxel characteristics in pediatri

20 dy, aged 18 to 30 years, without diabetes at baseline (1985-1986; N = 4251) were observed through 201

21 , 9 with IOP more than 10 mm Hg greater than baseline, 2 with IOP higher than 35 mm Hg, and 1 with an

22 ry outcome (eczema severity) was assessed at baseline, 2, 4, and 6 mo, by nurses blinded to treatment

23 lts, we measured serum endothelin-1 level at baseline (2000-2004; n=3538).

24 Relative to a single baseline 24-hour sodium measurement, the use of subseque

25 At baseline, 34% of subjects had steatosis grade 0 or 1, 39

26 Part I total mean (SD) scores increased from baseline 5.6 (4.1) to 7.7 (5.0) at year 2 in PD subjects

27 glyceride concentrations at 4 h (change from baseline: +59%, +59%, and +62%, respectively; P = 0.9).

28 nge over 12 months, based on measurements at baseline, 6 months, and 12 months.

29 s present in 128 of 1185 (11%) study eyes at baseline, 77% within 1 disc diameter of the foveal cente

30 SDs below normative standards on average at baseline, a mean placebo-associated improvement of less

31 ater longitudinal increase in NMS with lower baseline Abeta1-42 level is an important finding that wi

32 we show that the behavioral state alters the baseline activity levels and the temporal tuning of the

33 Baseline ADAU was negatively associated with age, female

34 risk of MCI and/or dementia by genotype and baseline age.

35 Vascular risk factors at ARIC baseline (age 45-64 years; risk factors included body ma

36 e at the third visit (2009-2013) relative to baseline among those participants with baseline eGFR >/=

37 aracteristics and (1) cardiac involvement at baseline and (2) the incidence of death, sudden death, a

38 d for dyspnea with the Rose Dyspnea Scale at baseline and 1 month after CTO PCI.

39 Values at baseline and 11.3 years were closely interrelated (r = 0

40 Changes in BMI between baseline and 12 weeks follow-up were assessed in 28 exce

41 235 patients with MMSE </=25 at baseline and 135 whose first study visit occurred more t

42 Participants had blinded central analyses of baseline and 24 h CTs, with dIVH defined as new intraven

43 measure was metabolite level changes between baseline and 24 weeks stratified by treatments.

44 d microbiologic parameters were evaluated at baseline and 3 and 6 months postoperatively.

45 plaque did not differ significantly between baseline and 3 months in either group (P >0.1 for all).

46 Clinical parameters were recorded at baseline and 3, 6, and 9 months; they included modified

47 At baseline and 4 months post-treatment, we measured (1) LV

48 ough a mean of three 24-h dietary recalls at baseline and 6 mo.

49 At baseline and 6 months post-transplant, we assessed mood,

50 VD) and choricapillary density using OCTA at baseline and 60 days after intravitreal dexamethasone im

51 ort design, we profiled 202 lipid species at baseline and after 1 y of intervention in the PREDIMED (

52 Participants underwent CMR at baseline and after 6-months of standard care.

53 tokine and chemokine levels were measured at baseline and after BV.

54 left eye for MUC5AC mucin immunostaining at baseline and after each treatment.

55 g memory and object recognition paradigms at baseline and after psychotogenic drug challenge, in conj

56 Patients were tested at baseline and annually for up to 5 years.

57 ive pneumococcal disease (IPD) from 2002 for baseline and appropriate later comparison periods to cal

58 agulation (PRP), as well as visual acuity at baseline and at 1 year.

59 d central macular thickness were recorded at baseline and at 1, 2, and 4 months after treatment with

60 temperature and vital signs were measured at baseline and at 5-15-minute intervals for 4 hours after

61 Meier method to assess variables obtained at baseline and at first follow-up RHC.

62 evaluated to determine if nGA was present at baseline and at follow-up using high-density Spectralis

63 ) completed any of the PRO questionnaires at baseline and at least one other assessment.

64 Social support at baseline and at one year was predicted by homelessness (

65 eta1, TIMP-1, MMP2 and MMP9 were measured at baseline and at the end of the 6-week study period.

66 and inflammatory parameters were assessed at baseline and at yearly visits.

67 walking for 1 kilometer and use of NSAIDs at baseline and death information at follow-up.

68 y higher during the treatment period than at baseline and end of therapy, Z >/= -2.27, p </= .023.

69 cizumab, 1.25 mg, or aflibercept, 2.0 mg, at baseline and every 4 weeks, with the primary outcome mea

70 J cancer selected for TAMK or TTIL completed baseline and follow-up HRQL assessments for up to 24 mon

71 Readers evaluated baseline and follow-up morphology on digital color image

72 At baseline and follow-up, patient-reported global AD sever

73 pectoris, or stroke, which developed between baseline and follow-up.

74 s, and correlated with cognitive measures at baseline and following 12 weeks of antipsychotic treatme

75 produce more inflammatory cytokines both at baseline and following endotoxin exposure when compared

76 -specific cardiovascular differences both at baseline and in disease is required to effectively consi

77 uality of Life-5 Dimensions health survey at baseline and over follow-up.

78 rovement post-TAVR was predicted by a mix of baseline and periprocedural factors translating into poo

79 lysis to compare SMC with GES, adjusting for baseline and stratification factors.

80 s, circulating PCSK9 levels were measured at baseline and then weekly at weeks 8 through 12.

81 uscularly by Biojector or electroporation at baseline and week 4 followed by intramuscular injection

82 Plasma and tissue HIV RNA correlated at baseline and when 9-month declines were compared, sugges

83 (kg)/height (m)2) at age 18-21 years, BMI at baseline, and change in BMI differed according to geneti

84 t in 50 (94%) of the 53 carotids with IPH at baseline, and it developed in five (7%) of the 40 caroti

85 t in 14 (26%) of the 53 carotids with IPH at baseline, and regression was present in 16 (30%).

86 e of 66 years, 73% were male, and the median baseline ankle-brachial index was 0.78.

87 caine self-administration by 67% relative to baseline at greater than 24 h post-infusion, the most ro

88 th period was small, but varied depending on baseline BCVA.

89 follow-up were for most agents as high as at baseline, because new infections had been acquired.

90 on facility, 3 (3%) of whom were infected at baseline, before treatment initiation.

91 e and found to have a negative FIT result at baseline (below the cut-off value of 10 mug Hb/ g feces)

92 ract surgery before enrollment compared with baseline bilateral phakia (HR, 1.63; 95% CI, 1.29-2.07;

93 short (3-6 months) treatment in relation to baseline bleeding risk.

94 We found that high baseline BMI was associated with a significantly slower

95 .05 and 0.0 +/- 0.03 g/cm(2) for groups with baseline body mass index (BMI; in kg/m(2)) >/=30 and <30

96 itive performance and start index than SN at baseline, both groups improved on improvement index (>30

97 n-3 deficiency reduces muscle performance at baseline, but ameliorates the progression of dystrophic

98 n of dominant species by biomass relative to baseline, but extensive changes in recruitment distribut

99 Compared to baseline, C4a level was four times higher 7 hours before

100 Preventive approaches should take baseline cardiovascular health into account.

101 ntention-to-treat-population with the use of baseline-carried-forward imputation for missing data.A t

102 cancers, with breast and prostate cancer as baseline categories for women and men, respectively-to e

103 d the presence of hyperplastic polyps in the baseline CC, showed a statistically significant differen

104 Fifty-one of 1452 participants with baseline CD4 count <350 cells/muL developed IRIS.

105 onitored male population, observed effect of baseline central adiposity on future periodontitis progr

106 The association between baseline ceramide score and incident CVD varied signific

107 ciation between CTG expansion size and other baseline characteristics and (1) cardiac involvement at

108 ortality hazard ratios after controlling for baseline characteristics and disease severity.

109 D compared with those without, adjusting for baseline characteristics and postprocedure medications.

110 with standardized protocols and adjusted for baseline characteristics by Cox regression.

111 Baseline characteristics were determined from administra

112 In the ILLUMENATE Pivotal Study, baseline characteristics were similar between groups: 50

113 The baseline characteristics, development of early dermatolo

114 ching was used to correct for differences in baseline characteristics.

115 black and white patients after adjusting for baseline characteristics.

116 l has revealed a strong predictive value for baseline cholinesterase and bilirubin levels with a high

117 nerability assessment whereby we compare the baseline climate of the protected area network in North

118 Baseline clinical data and GEP class assignments were ob

119 ducation, subjective memory concerns, poorer baseline cognitive performance, and family history of de

120 and monopoly (HHI value of 10 000) levels of baseline competition were associated with price changes

121 fter 8 years of follow-up, participants with baseline concentrations of 8-10 mug fHb/g had a higher c

122 of 790 participants (37 overlapping cases)].Baseline concentrations of cholesterol esters (CEs) were

123 adult achieved the goals effortlessly; or a Baseline condition.

124 (n=21) had reduced higher visual function at baseline, cortical thinning in parietal, occipital and f

125 Among 265 eyes without any GA on baseline CP, 70 (26.4%) developed CP-visible GA.

126 ith a positive result in phase 1, the median baseline cycle-threshold values (higher values indicate

127 patients with myelofibrosis irrespective of baseline cytopenias.

128 Among the 398 patients with baseline data (mean age, 47 [SD, 16.0] years; 63% women;

129 ion Algorithm) software, adjusted for age at baseline data collection.

130 The findings of this study provide baseline data for ocean plastic mass balance exercises,

131 We examined baseline data from 3,987 subjects without diabetes in th

132 Nonparametric tests compared baseline data, whereas repeated-measures analyses assess

133 Analyte concentrations were compared with baseline (day 0) measures on the seventh day of biotin t

134 Surveys were conducted at baseline (December 2011 through May 2012) and after the

135 as among younger delirious patients without baseline dementia.

136 Baseline demographic and clinical predictors of ICB were

137 Baseline demographics were well balanced among the cohor

138 Mean (SD) baseline deseasonalized 25(OH)D concentration was 26.5 (

139 We used PET and [(11)C]raclopride to assess baseline DRD2 availability in 91 participants.

140 Baseline DRIL predicted 8-month improvement in BCVA (poi

141 Baseline echocardiography and a composite endpoint (card

142 75; 95% CI, 2.31-19.7; P < .001), and higher baseline EDSS score (HR per point, 1.21; 95% CI, 1.06-1.

143 ve to baseline among those participants with baseline eGFR >/=60 ml/min per 1.73 m(2) At baseline, me

144 loyed men and women 18 to 74 years of age at baseline examination in 1967 to 1973.

145 Baseline examinations were done between 2006 and 2010.

146 ene expression in the recovery group back to baseline expression observed in sham-surgery controls.

147 P = .0002) and between EZW constriction and baseline EZW (rs = 0.714, P < .0001).

148 ery and anesthesia exposure versus patients' baseline factors and hospital course.

149 es among the treatment groups with regard to baseline features, intraoperative surgery time, intraope

150 rrespective of a history of exacerbations or baseline FEV1.

151 provide an easily understandable and useful baseline for clinicians and managers.

152 e that this work will provide a standardized baseline for future work to optimize recommended diets f

153 These results provide an empirical baseline for tagging experiments, life histories extrapo

154 ressures and to identify meaningful temporal baselines for biodiversity.

155 Control teams (n=17) returned 366 baseline forms.

156 g 21870 participants (20163 free from CVD at baseline) from 3 studies: Cardiovascular Health Study (C

157 the peak high frequency were correlated with baseline functional connectivity within the DMN and base

158 characterized the effect of PKM2 deletion on baseline functioning and survival of photoreceptors over

159 mab from randomization with gradable DRSS on baseline fundus photographs.

160 -120 mg once-daily dose groups regardless of baseline Gag polymorphisms.

161 On multivariate logistic regression, lower baseline GDF-15 was associated with improved global long

162 for prediction of clinical phenotypes using baseline genome-wide expression data that makes use of p

163 ISA (estimated geometric mean fold rise from baseline [GMFR] = 1.6 [95% confidence interval [CI], 1.4

164 At baseline, greater individual-level safety was associated

165 nce compared with children without asthma at baseline (hazard ratio, 1.51; 95% confidence interval, 1

166 verage (0%, 3%, 6%, 12%, or 24%) and varying baseline HCV prevalence in people who inject drugs (30%,

167 iable linear regression, with adjustment for baseline health status and accounting for clustering of

168 of the aspirate in relation to the patient's baseline hematocrit.

169 RM, SHRM, and PED thickness, and presence of baseline hemorrhage were all significant predictors of n

170 7.3 per 100 person-years among patients with baseline high-grade dysplasia (95% CI 4.2-12.5).

171 parental education was associated with lower baseline HRQOL (P < 0.05).

172 In contrast, the baseline hs-cTnT levels on admission were not related to

173 NP at 4 months was inversely correlated with baseline hs-TnT (r=-0.27, P=0.001).

174 reotyped 3-5 Hz Vm oscillations where the Vm baseline hyperpolarized as the Vm underwent high amplitu

175 ria (controls: 35-fold; KO: 5400-fold versus baseline), hypoalbuminemia, reduced GFR, and marked glom

176 hange in device parameters (>50% change from baseline) immediately after MRI was a decrease in P-wave

177 m all participants who were premenopausal at baseline in 1991; over 1.13 million person-years, 2041 w

178 o correlation was found between changes from baseline in BCVA and CRT in pooled AMD trial data.

179 Primary outcome was change from baseline in best-corrected visual acuity in uveitic eyes

180 The adjusted mean change from baseline in body weight in the surgery group was -45.0 k

181 coronary artery calcium (CAC) assessment at baseline in individuals with established metabolic syndr

182 the NEPTR may be predicted by FA metrics at baseline in patients with glioblastoma.

183 Changes from baseline in pulmonary function at Week 48 were analyzed

184 wed significant improvements at week 24 from baseline in SGRQ total score (least squares mean [SE] ch

185 he primary endpoint was the mean change from baseline in the St George's Respiratory Questionnaire (S

186 erence between the two groups in change from baseline in total cholesterol to HDL-cholesterol ratio.

187 mmunities have rarely been demonstrated, and baseline information on current impacts of environmental

188 r diabetes duration of 10 years or longer at baseline, insulin use, and glycemic control.

189 ductance or cell-impermeant dye flux but the baseline ion conductance was more variable in Sox10::Cre

190 compare the outcomes of patients with large baseline ischemic cores on CTP undergoing ET with the ou

191 Of 794 joints with baseline joint-specific hard tissue diagnoses of DJD, pr

192 y on missing, insufficient, or early or late baseline laboratory data.

193 3.91; 95% CI, 1.62-9.42) before returning to baseline levels during ongoing treatment (IRR, 1.35; 95%

194 Lower baseline levels of adiponectin significantly predicted k

195 sed MBNL1 expression greater than double the baseline levels.

196 Baseline liver fat (AUROC 0.84; 95%CI: 0.76-0.92) predic

197 Baseline liver fat (OR 2.17; 95%CI: 1.05-4.46) was an in

198 3.3 per 100 person-years among patients with baseline low-grade dysplasia (95% CI 1.5-7.2), and 7.3 p

199 evere bioprosthetic PAS undergoing redo AVR, baseline LV-GLS provides incremental prognostic use over

200 In eyes with no baseline MA, presence of SHRM, SHRM, and PED thickness,

201 atherosclerosis, 40 participants with IPH at baseline magnetic resonance (MR) imaging (53 carotids wi

202 05% [interquartile range {IQR}, 0.0-0.7%] of baseline; males: 3.4% [IQR, 0.4%-32.9%] of baseline; P <

203 ollow-up (n = 4), and offspring with missing baseline MDD data (n = 2) were excluded.

204 ds activated, compared with the preoperative baseline mean TRS score.

205 baseline eGFR >/=60 ml/min per 1.73 m(2) At baseline, mean age was 55 years old, 37% of participants

206 thout SCT, participants with SCT had similar baseline measures of fitness in cross-section, including

207 eatures of immune suppression, with dampened baseline microglial activity.

208 ed virological response rates, LT costs, and baseline Model for End-Stage Liver Disease score (DCC an

209 We used genetic data and baseline molecular and clinical variables from patients

210 In addition, baseline MOR availability in the cingulate and orbitofro

211 a (DIPG) and to correlate these metrics with baseline MRI apparent diffusion coefficient (ADC) histog

212 Offspring with MDD before the study or at baseline (n = 27), offspring with an episode of MDD that

213 ly participants who had suicidal ideation at baseline (N=167).

214 essure (IOP) more than 10 mm Hg greater than baseline; ocular adverse events in the bevacizumab group

215 red to the single-task model from an average baseline of 78.4%.

216 owever, it was due to effect modification by baseline overweight status.

217 f baseline; males: 3.4% [IQR, 0.4%-32.9%] of baseline; P < .001).

218 rly tears before the tear (+5.6 letters from baseline; P = 0.01), decreased immediately after the tea

219 e functional connectivity within the DMN and baseline parasympathetic tone respectively, highlighting

220 At baseline, participants were counseled extensively about

221 Baseline patient characteristics and reaction results we

222 ficantly larger in hyperperfused compared to baseline-perfused areas.

223 In a comparison of the baseline period with the EOS calculator period, blood cu

224 in all periods (5.2 per 100000 births in the baseline period, 1.9 per 100000 births in the learning p

225 irologic relapse in which the HCV present at baseline persisted in the liver or another compartment a

226 Baseline PETco2 was 38.9 +/- 0.8 (mean +/- SD) mm Hg (ra

227 rest and during 6-min hypercapnic plateaus (baseline; PETco2 at 50, 55, and 60 mm Hg; repeat of PETc

228 tem to eltrombopag or placebo, stratified by baseline platelet count (<10 x 10(9) platelets per L vs

229 GFR (30-day follow-up eGFR>/=10% higher than baseline pre-TAVR), worsened eGFR (>/=10% lower), or no

230 The baseline prevalence of GSD was 5.7% of the included part

231 SAEs, assigned drug and dosing regimen, and baseline prognostic factors were requested from the lead

232 ox proportional hazards models adjusting for baseline prognostic factors.

233 Data were acquired according to a double baseline protocol in which PET examinations were repeate

234 f host antitumour immunity as represented by baseline quantities of TILs in patients with advanced HE

235 We used exposure information on the baseline questionnaire to identify exposures of interest

236 change in serum phosphate concentration from baseline (randomization) to end of treatment.

237 Despite this high baseline rate, we show that NAGC slows down as duplicate

238 ols (HCs) underwent 3 experimental sessions (baseline, real-rTMS, sham-rTMS), all including an N-back

239 Compared with their baseline reports, patients who underwent implant reconst

240 sus four (<1%) of 518 contacts uninfected at baseline, respectively (p=1.00).

241 However, after adjustment for differences in baseline risk factors, IVUS-guidance was associated with

242 cid synthesis were significantly enriched in baseline samples from CD patients achieving remission.

243 Mean baseline SBP and DBP were 139.7+/-15.6 and 78.1+/-11.9 m

244 ach serial time point were compared with the baseline score by using paired t tests (level of signifi

245 Baseline separation is achieved on all covalent biotin a

246 1 and GC gene may contribute to variation in baseline serum 25(OH)D concentration, and that polymorph

247 regression, only age younger than 50 years, baseline serum cancer antigen 19-9 level less than 200 U

248 At baseline, several PFAS were cross-sectionally associated

249 Baseline severities and features of initial DR are progn

250 The interaction between baseline severity and treatment was significant (beta=0.

251 eatment effect varied, however, depending on baseline severity of hypoxemia (P = 0.0003), with harm i

252 The emergence of novelty is baseline specific and, during the early-Holocene, was mi

253 achieved prior to week 6 (VISUAL-1) and from baseline state (VISUAL-2) to the final or early terminat

254 exhibit improved motor function, relative to baseline states during wake periods.

255 up of 493 men met criteria for AAMI based on baseline subjective memory complaints and objective memo

256 The baseline survey (enumeration) was carried out between Au

257 lation (27.2%, 95% CI 21.4-33.7) than in the baseline survey population (4.3%, 1.5-7.1).

258 n these villages were enrolled in 2013 for a baseline survey, then re-enrolled in 2015 for an endline

259 luded reduction in intraocular pressure from baseline, survival analysis, and reduction in the number

260 n SVI with nitroprusside varied inversely to baseline SVI and demonstrated improvement in LF only (3

261 ncluded 16 MDD patients who underwent MRI at baseline then 24 h following intravenous infusion of ket

262 provement of >/=15 letters from preoperative baseline through day 90 (77.2% vs. 67.7% [P = 0.009] and

263 rence between PM+ and EUC in the change from baseline to 3 months on the GHQ-12 was 3.33 (95% CI 1.86

264 The primary outcome was change from baseline to 36 months on a composite Z score combining f

265 increased from 64% (703 of 1092 patients) at baseline to 67% (732 of 1092 patients) at 1 year (differ

266 The primary outcome was change from baseline to 8 weeks in accelerometer-measured daily time

267 ion group from 68% (804 of 1184 patients) at baseline to 80% (943 of 1184 patients) at 1 year (differ

268 ommunication was significantly improved from baseline to after intensive speech and language treatmen

269 SD 4.94]; 95% CI 1.49 to 3.72), but not from baseline to after treatment deferral (-0.03 points [4.04

270 1985 to 2009, and the median follow-up from baseline to CRC diagnosis was 8.2 y.

271 id not show a decrease of more than 80% from baseline to day 4 (20% vs 10%; p = 0.001).

272 an estimated glomerular filtration rate from baseline to month 6 (Nankivell) was noninferior for TacH

273 effect sizes demonstrated improvements from baseline to postassessment for the SHUTi participants (r

274 Least squares mean change from baseline to week 6 in AIMS dyskinesia score was -3.2 for

275 response assessed with PET/CT combined with baseline total metabolic tumor volume (TMTV) could detec

276 On multivariate analysis, baseline total nevus count (adjusted odds ratio, 9.08; 9

277 ic media and passive sampler phases; aquatic baseline toxicity; and relevant diffusion coefficients.

278 Compared with the mean baseline TRS score of 57.0 (SD 10.2), the mean score at

279 the surgery group who had type 2 diabetes at baseline, type 2 diabetes remitted in 66 of 88 patients

280 esults suggest that risk stratification from baseline ulcer characteristics can identify those at hig

281 mean diffusivity (MD) was unchanged despite baseline values lower than controls (p < 0.05), and frac

282 was trained to predict individual risk from baseline values of cholinesterase, bilirubin, type of pr

283 Comparing pediatric liver stiffness to adult baseline values to detect pediatric liver mechanical abn

284 red in six (<1%) of 795 contacts infected at baseline versus four (<1%) of 518 contacts uninfected at

285 tients underwent surgery 1 month after their baseline visit for implantation of the dual lead DBS sys

286 ilar results were seen for participants with baseline vitamin D deficiency and for secondary outcomes

287 98 degrees eccentricity between 6 months and baseline was 0.036 (95% CI, -0.037 to 0.110) (P = .33).

288 found that greater hippocampal activation at baseline was associated with increased Abeta accumulatio

289 ng white matter distribution volume ratio at baseline was correlated with enlarging T2-hyperintense l

290 e mean reduction in maximum keratometry from baseline was equivalent with 2-minute and 5-minute ribof

291 Total fat intake 10 years before baseline was significantly associated with increased ris

292 Higher TG concentrations at baseline were associated with an increased risk of all d

293 Two drusen suspicious for nGA at baseline were identified, but neither druse developed GA

294 hood socioeconomic status (SES), measured at baseline, were also examined as explanations for subsequ

295 ing exoskeleton-assisted walking compared to baseline, while knee flexor activity was elevated in som

296 itoring, 27 (58.7% N = 46) kept a BCVA above baseline with 18 of those (39% N = 46) maintaining a 10-

297 ted geometric mean ratio of UACR change from baseline with empagliflozin was -7% (95% CI -12 to -2; p

298 ly diagnosed or screen-detected) diabetes at baseline, with an overall incidence rate of 2.8 per 1,00

299 At baseline, youths from London and Dublin sites were asses

300 more during the treatment period than at the baseline, Z >/= -1.97, p </= .04.